Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gali Heimer

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Clinical Genetics|October 19, 2024
Biallelic PIGM Coding Variant Causes Intractable Epilepsy and Intellectual Disability Without Thrombotic EventsGali Heimer, Ben Pode-Shakked, Dina Marek-Yagel, et al.
Frontiers in Neurology|October 7, 2022
Felbamate for pediatric epilepsy-should we keep on using it as the last resort?Shira Rabinowicz, Tal Schreiber, Gali Heimer, et al.
Autophagy|November 20, 2020
Lysosomal targeting of autophagosomes by the TECPR domain of TECPR2Milana Fraiberg, Bat-Chen Tamim-Yecheskel, Kamilya Kokabi, et al.
Molecular Genetics and Metabolism Reports|September 9, 2020
Four patients with D-bifunctional protein (DBP) deficiency: Expanding the phenotypic spectrum of a highly variable diseaseYuval E Landau, Gali Heimer, Ortal Barel, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 23, 2021
Delineation of the phenotype of MED17-related disease in Caucasus-Jewish familiesAviva Fattal-Valevski, Liat Ben Sira, Tally Lerman-Sagie, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 28, 2023
Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 studyChristopher Keary, Lynne M Bird, Marie-Claire de Wit, et al.
NPJ Genomic Medicine|March 14, 2025
Unraveling MECP2 structural variants in previously elusive Rett syndrome cases through IGV interpretationTomer Poleg, Noam Hadar, Gali Heimer, et al.
Neurology|January 14, 2021
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman SyndromeLynne M Bird, Cesar Ochoa-Lubinoff, Wen-Hann Tan, et al.
American Journal of Medical Genetics. Part A|June 24, 2026
Severe ADEM-Like Neuroinflammatory Disease and Cerebrovascular Fragility With Recurrent Pseudoaneurysms and Moyamoya in a Familial Germline CBL Mutation: Expanding the Clinical PhenotypeMichal Bar-Hakim, Anat Abramovich, Sara Via-Dorembus, et al.
Journal of Child Neurology|April 22, 2015
CAOS-Episodic Cerebellar Ataxia, Areflexia, Optic Atrophy, and Sensorineural Hearing Loss: A Third Allelic Disorder of the ATP1A3 GeneGali Heimer, Yair Sadaka, Lori Israelian, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Clinical Genetics|October 19, 2024
Biallelic PIGM Coding Variant Causes Intractable Epilepsy and Intellectual Disability Without Thrombotic EventsGali Heimer, Ben Pode-Shakked, Dina Marek-Yagel, et al.
Frontiers in Neurology|October 7, 2022
Felbamate for pediatric epilepsy-should we keep on using it as the last resort?Shira Rabinowicz, Tal Schreiber, Gali Heimer, et al.
Autophagy|November 20, 2020
Lysosomal targeting of autophagosomes by the TECPR domain of TECPR2Milana Fraiberg, Bat-Chen Tamim-Yecheskel, Kamilya Kokabi, et al.
Molecular Genetics and Metabolism Reports|September 9, 2020
Four patients with D-bifunctional protein (DBP) deficiency: Expanding the phenotypic spectrum of a highly variable diseaseYuval E Landau, Gali Heimer, Ortal Barel, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 23, 2021
Delineation of the phenotype of MED17-related disease in Caucasus-Jewish familiesAviva Fattal-Valevski, Liat Ben Sira, Tally Lerman-Sagie, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 28, 2023
Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 studyChristopher Keary, Lynne M Bird, Marie-Claire de Wit, et al.
NPJ Genomic Medicine|March 14, 2025
Unraveling MECP2 structural variants in previously elusive Rett syndrome cases through IGV interpretationTomer Poleg, Noam Hadar, Gali Heimer, et al.
Neurology|January 14, 2021
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman SyndromeLynne M Bird, Cesar Ochoa-Lubinoff, Wen-Hann Tan, et al.
American Journal of Medical Genetics. Part A|June 24, 2026
Severe ADEM-Like Neuroinflammatory Disease and Cerebrovascular Fragility With Recurrent Pseudoaneurysms and Moyamoya in a Familial Germline CBL Mutation: Expanding the Clinical PhenotypeMichal Bar-Hakim, Anat Abramovich, Sara Via-Dorembus, et al.
Journal of Child Neurology|April 22, 2015
CAOS-Episodic Cerebellar Ataxia, Areflexia, Optic Atrophy, and Sensorineural Hearing Loss: A Third Allelic Disorder of the ATP1A3 GeneGali Heimer, Yair Sadaka, Lori Israelian, et al.
Pageof 6